about
5-Isopropyl-imidazolidine-2,4-dione monohydrateS-Phenyl 4-meth-oxy-benzothio-ate.Methyl 3-[(6-nitro-4-oxo-3-phenyl-3,4-di-hydro-quinazolin-2-yl)sulfan-yl]propano-ateSynthesis, anticancer and apoptosis-inducing activities of quinazoline-isatin conjugates: epidermal growth factor receptor-tyrosine kinase assay and molecular docking studies.Synthesis and antitumor evaluation of trimethoxyanilides based on 4(3H)-quinazolinone scaffolds.Synthesis, biological evaluation and molecular modeling study of thiadiazolo[3,2-a][1,3]diazepine analogues of HIE-124 as a new class of short acting hypnotics.Synthesis and potential antitumor activity of 7-(4-substituted piperazin-1-yl)-4-oxoquinolines based on ciprofloxacin and norfloxacin scaffolds: in silico studies.Synthesis, antitumor and antimicrobial activity of some new 6-methyl-3-phenyl-4(3H)-quinazolinone analogues: in silico studies.1-Acetyl-5-meth-oxy-4-(phenyl-sulfan-yl)imidazolidin-2-one.3-[2-(4-Fluoro-phen-yl)-2-oxoeth-yl]-5,5-di-phenyl-imidazolidine-2,4-dione.2-Meth-oxy-4,6-di-phenyl-nicotino-nitrile.3-Amino-5,5-di-phenyl-imidazolidine-2,4-dione.4-[(1,3-Dioxoisoindolin-2-yl)meth-yl]benzene-sulfonamide.N-(12-Amino-9,10-di-hydro-9,10-ethano-anthracen-11-yl)-4-methyl-benzene-sulfonamide.Design, synthesis and biological evaluation of some novel substituted quinazolines as antitumor agents.Design, synthesis and biological evaluation of 2-mercapto-3-phenethylquinazoline bearing anilide fragments as potential antitumor agents: molecular docking study.Design, synthesis, single-crystal and preliminary antitumor activity of novel arenesulfonylimidazolidin-2-ones.Synthesis and anticonvulsant activity of some new thiazolo[3,2-a][1,3]diazepine, benzo[d]thiazolo[5,2-a][12,6]diazepine and benzo[d]oxazolo[5,2-a][12,6]diazepine analogues.Non-classical antifolates. Part 2: synthesis, biological evaluation, and molecular modeling study of some new 2,6-substituted-quinazolin-4-ones.Synthesis and biological evaluation of some novel cyclic-imides as hypoglycaemic, anti-hyperlipidemic agents.Synthesis and antitumor evaluation of novel cyclic arylsulfonylureas: ADME-T and pharmacophore prediction.Synthesis and antitumor evaluation of novel diarylsulfonylurea derivatives: molecular modeling applications.Substituted quinazolines, part 3. Synthesis, in vitro antitumor activity and molecular modeling study of certain 2-thieno-4(3H)-quinazolinone analogs.Solvatochromism, DNA binding, antitumor activity and molecular modeling study of mixed-ligand copper(II) complexes containing the bulky ligand: bis[N-(p-tolyl)imino]acenaphthene.2-{[2-Methyl-3-(2-methyl-phen-yl)-4-oxo-3,4-dihydro-quinazolin-8-yl]-oxy}acetonitrile.2-Methyl-3-(2-methyl-phen-yl)-4-oxo-3,4-dihydro-quinazolin-8-yl 4-methyl-benzoate.2-Methyl-sulfanyl-9H-1,3,4-thia-diazolo[2,3-b]quinazolin-9-one.1-Acetyl-4-(phenyl-sulfan-yl)imidazolidin-2-one.2-(4-Meth-oxy-phen-yl)-4-oxo-4-phenyl-butane-nitrile.2-Methyl-3-(2-methyl-phen-yl)-7-nitro-quinazolin-4(3H)-one.2-(2-{[4-Oxo-3-(2-phenyl-eth-yl)-3,4-dihydro-quinazolin-2-yl]sulfan-yl}eth-yl)-2,3-dihydro-1H-isoindole-1,3-dione2-Methyl-3-(2-methyl-phen-yl)-4-oxo-3,4-dihydro-quinazolin-8-yl thio-phene-2-carboxyl-ate.2,6-Bis[(S)-1-phenyl-eth-yl]-1H,5H-pyrrolo-[3,4-f]isoindole-1,3,5,7(2H,6H)-tetrone.2-Methyl-3-(2-methyl-phen-yl)-4-oxo-3,4-dihydro-quinazolin-8-yl 4-bromo-benzene-1-sulfonate.(Adamantan-1-yl)(phenyl-sulfan-yl)methanone.N-(3-Amino-bicyclo-[2.2.1]heptan-2-yl)-4-methyl-benzene-sulfonamide.2-Methyl-3-(2-methyl-phen-yl)-4-oxo-3,4-dihydro-quinazolin-8-yl 4-chloro-benzoate(11R,12S)-16-Amino-tetra-cyclo-[6.6.2.0(2,7).0(9,14)]hexa-deca-2(7),3,5,9(14),10,12-hexaen-15-ol.8-Benz-yloxy-2-methyl-3-(2-methyl-phenyl)quinazolin-4(3H)-one.6-Methyl-3-phenyl-2-sulfanyl-idene-1,2,3,4-tetra-hydro-quinazolin-4-one.
P50
Q35744268-B1EF79DD-3C56-4E55-AAF7-449039893751Q35933356-6372FBA2-D7C9-4390-89C7-E9FD2BE53391Q37163852-5F3E7586-7098-435F-9113-B0321ABAA019Q38696988-86B169D7-4FA6-4D07-BBE8-FAF68BA400D4Q38793168-95F046D2-CEB3-4430-9BC2-953EE673023DQ38824120-18AD2658-1A8F-4638-B6F7-812BBF5165E0Q38847831-2A4BA037-491B-4F02-B693-53A90F3A1706Q38854542-135461C4-88D5-4E5A-9D03-B8469FB08221Q38943470-A5C5B961-818B-4C69-9B2B-AB5BC0DF3554Q38944445-E5606529-320C-4DF7-AE7A-063939326659Q38944468-260F897D-A1E2-4CE3-AF41-43EE1B51BA6CQ38945131-906D3A4A-CD7D-43AE-A52B-7396F88C6BB4Q38946064-85977A4F-AB2E-447F-90FC-7FDFCF4EF0B1Q38946983-EDE056B5-0EAA-49E3-8F9E-1F3E039D9EA5Q39001397-71DDCDC4-DCC9-4D77-9A2E-AA7C01BC71D1Q39150635-267500EF-390C-467D-A16F-86E710A68A66Q39399546-4F905FA9-7996-490B-B383-BDDAAEAD6153Q39702023-58E1B78C-41CC-4673-9F5E-372BF6CEDCEDQ39721353-46A14256-F64C-4643-834B-A38CB20EA920Q39725649-EFEA12D5-3442-4C48-812F-A5C80A96652CQ39726577-8409118B-B6F1-410D-BC0E-B93782895B0AQ39770618-524DCA54-914E-45D6-AF45-96750525E2E6Q39925421-2E0ADDEF-A62D-49E5-A95D-AF2CCFFB79EDQ40146820-8FB321E6-85CC-4134-B2C8-60041C3466A3Q41807521-8D4B6103-9048-43C2-9312-6E6B763989FFQ41810731-436E76B1-6E2E-4C52-8199-6A2FC8A77874Q41867541-F33AA5E7-47D6-4913-9387-75E78C1E02F6Q41955167-22D825DA-8C84-407C-BC7F-7405485E8DCEQ42002942-CFA99269-46DC-40A1-ACA0-82B739B3B3B4Q42066936-081AE83D-C5E7-4A0E-8814-3776C275DF46Q42076900-43A8DD89-826A-46A3-82A0-917854F3EE0FQ42111146-E38AFFD6-4099-4F8D-B56E-F00648518267Q42123570-7F8069E5-8689-4662-8588-CB306B025502Q42141983-C393EC80-4DDD-4EE5-B435-EE8DFFE86068Q42177563-EE3C86A7-C68B-44A7-8DA4-7EE12774DA8DQ42231280-F32DB54B-7D55-4F1E-8D22-2C2E7D10AB15Q42231309-C8C5284E-C465-4BC7-A01F-68C2F94AB949Q42232398-7054E7FC-8992-4CF7-B508-1A7A05407CF7Q42591297-BA76E268-2674-4880-8A2D-1B6EDD9F3F8BQ42591303-CDB83927-96A1-48C8-A6DB-939FA9F55765
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Alaa A-M Abdel-Aziz
@ast
Alaa A-M Abdel-Aziz
@en
Alaa A-M Abdel-Aziz
@es
Alaa A-M Abdel-Aziz
@nl
type
label
Alaa A-M Abdel-Aziz
@ast
Alaa A-M Abdel-Aziz
@en
Alaa A-M Abdel-Aziz
@es
Alaa A-M Abdel-Aziz
@nl
altLabel
Alaa A.M. Abdel-Aziz
@en
prefLabel
Alaa A-M Abdel-Aziz
@ast
Alaa A-M Abdel-Aziz
@en
Alaa A-M Abdel-Aziz
@es
Alaa A-M Abdel-Aziz
@nl
P1153
P1053
A-9321-2012
P106
P1153
57190973558
57200135911
8605268800
P31
P3829
P496
0000-0002-3362-9337